title: Double heterozygosity for mutations in the beta-myosin heavy chain and in the cardiac myosin binding protein C genes in a family with hypertrophic cardiomyopathy.
abstract: Familial hypertrophic cardiomyopathy is a genetically heterogeneous autosomal dominant disease, caused by mutations in several sarcomeric protein genes. So far, seven genes have been shown to be associated with the disease with the beta-myosin heavy chain (MYH7) and the cardiac myosin binding protein C (MYBPC3) genes being the most frequently involved. We performed electrocardiography (ECG) and echocardiography in 15 subjects with hypertrophic cardiomyopathy from a French Caribbean family. Genetic analyses were performed on genomic DNA by haplotype analysis with microsatellite markers at each locus involved and mutation screening by single strand conformation polymorphism analysis. Based on ECG and echocardiography, eight subjects were affected and presented a classical phenotype of hypertrophic cardiomyopathy. Two new mutations cosegregating with the disease were found, one located in the MYH7 gene exon 15 (Glu483Lys) and the other in the MYBPC3 gene exon 30 (Glu1096 termination codon). Four affected subjects carried the MYH7 gene mutation, two the MYBPC3 gene mutation, and two were doubly heterozygous for the two mutations. The doubly heterozygous patients exhibited marked left ventricular hypertrophy, which was significantly greater than in the other affected subjects. We report for the first time the simultaneous presence of two pathological mutations in two different genes in the context of familial hypertrophic cardiomyopathy. This double heterozygosity is not lethal but is associated with a more severe phenotype.
authors.affiliation: Service de Biochimie B, Groupe Hospitalier Pitié-Salpêtrière, Paris, France.
authors.forename: P
authors.initials: P
authors.lastname: Richard
authors.forename: R
authors.initials: R
authors.lastname: Isnard
authors.forename: L
authors.initials: L
authors.lastname: Carrier
authors.forename: O
authors.initials: O
authors.lastname: Dubourg
authors.forename: Y
authors.initials: Y
authors.lastname: Donatien
authors.forename: B
authors.initials: B
authors.lastname: Mathieu
authors.forename: G
authors.initials: G
authors.lastname: Bonne
authors.forename: F
authors.initials: F
authors.lastname: Gary
authors.forename: P
authors.initials: P
authors.lastname: Charron
authors.forename: M
authors.initials: M
authors.lastname: Hagege
authors.forename: M
authors.initials: M
authors.lastname: Komajda
authors.forename: K
authors.initials: K
authors.lastname: Schwartz
authors.forename: B
authors.initials: B
authors.lastname: Hainque
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002312:Cardiomyopathy, Hypertrophic / Q000235:genetics* / Q000473:pathology; D002352:Carrier Proteins / Q000235:genetics*; D005260:Female; D005838:Genotype; D006239:Haplotypes; D006579:Heterozygote; D006801:Humans; D008297:Male; D008875:Middle Aged; D009154:Mutation; D009206:Myocardium / Q000473:pathology*; D009218:Myosins / Q000235:genetics*; D010375:Pedigree; D010641:Phenotype; D000099163:Myosin Binding Protein C
chemical_list: D002352:Carrier Proteins; D009218:Myosins; D000099163:Myosin Binding Protein C